ATS View
한국어

HLB Panagene KRX:046210KOSDAQ

HLB파나진 · Korean news coverage and regulatory filings, organized.

한국어
Articles, 24h0
Articles, 7 days13
DART filings, 7 days0
Articles tracked24since Sep 11

In Q2 2026, HLB Panagene reported revenue of ₩3.7bn, up 1.9% year on year, and an operating loss of ₩158m. HLB Panagene (HLB파나진) appeared in 13 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Sep 29 with 12 articles.

Filing signals 4 quarters of losses Screener

HLB Panagene quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩3.7bn+1.9%−₩158m
margin −4.3%		₩1.6bn
Q1 2026₩3.1bn-11.6%−₩749m
margin −23.9%		−₩1.1bn
Q4 2025 derived₩4.2bn+21.9%−₩1.7bn
margin −39.6%		−₩3.6bn
Q3 2025₩3.6bn-5.6%−₩829m
margin −22.8%		−₩164m
Q2 2025₩3.6bn+47.7%−₩200m
margin −5.5%		₩1.2bn
Q1 2025₩3.5bn+3.9%−₩733m
margin −20.7%		−₩584m
Q4 2024 derived₩3.5bn+30.8%−₩270m
margin −7.8%		₩1.1bn
Q3 2024₩3.9bn+24.8%−₩256m
margin −6.7%		−₩122m

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

HLB Panagene top stories 2 weeks, by number of outlets

  1. 1
    HLB파나진, 면역진단 개발 사업 정리...AOC·공간단백체 신사업 집중
    6 outlets · 6 articlesFirst report Sep 18 16:33 팍스경제TV
  2. 2
    HLB파나진, AOC 개발 기반 PNA 화학적 변형 기술 글로벌 학회서 공개
    4 outlets · 4 articlesFirst report Sep 29 10:15 머니투데이
  3. 3
    HLB파나진, 국제학회서 PNA 화학적 변형 기술 발표
    3 outlets · 3 articlesFirst report Sep 29 10:21 뉴스핌
  4. 4
    HLB파나진, 美 핵산 치료제 학회 ‘OTS 2026’서 PNA 연구 성과 발표
    1 outlets · 1 articlesFirst report Sep 29 10:37 더바이오
  5. 5
    HLB파나진, 자회사 2년 만에 청산…일부 고용승계도 없었다
    1 outlets · 1 articlesFirst report Sep 18 16:04 블로터
  6. 6
    HLB파나진, PNA 기술 치료제 확장…AOC 개발 기반 마련
    1 outlets · 1 articlesFirst report Sep 29 14:48 EBN

Latest HLB Panagene news Korean headlines